Zentek Ltd. (ZTEK)
NASDAQ: ZTEK · Real-Time Price · USD
0.8105
-0.0420 (-4.93%)
At close: Oct 22, 2025, 4:00 PM EDT
0.7861
-0.0244 (-3.01%)
Pre-market: Oct 23, 2025, 5:18 AM EDT
Zentek Revenue
Zentek had revenue of 57.80K CAD in the quarter ending June 30, 2025, with 952.96% growth. This brings the company's revenue in the last twelve months to 924.80K, up 2,519.47% year-over-year. In the fiscal year ending March 31, 2025, Zentek had annual revenue of 872.50K with 2,826.26% growth.
Revenue (ttm)
924.80K CAD
Revenue Growth
+2,519.47%
P/S Ratio
126.96
Revenue / Employee
54,400 CAD
Employees
17
Market Cap
86.09M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 872.50K | 842.68K | 2,826.26% |
Mar 31, 2024 | 29.82K | -43.04K | -59.07% |
Mar 31, 2023 | 72.86K | -274.33K | -79.02% |
Mar 31, 2022 | 347.18K | 344.83K | 14,642.38% |
Mar 31, 2021 | 2.36K | - | - |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ZTEK News
- 13 hours ago - Zentek Announces Closing of Non-Brokered Private Placement of Units for Gross Proceeds of $2,479,227 - Newsfile Corp
- 2 days ago - Zentek Announces Upsizing of Non-Brokered Private Placement to up to $2,500,000 - Newsfile Corp
- 16 days ago - Zentek Subsidiary Albany Graphite Corp. Provides Additional Positive Nuclear Suitability Testing Results - Accesswire
- 21 days ago - Zentek Announces Non-Brokered Private Placement of Units for up to $2,000,000 - Newsfile Corp
- 27 days ago - Zentek Announces Voting Results of Annual and Special Meeting - Newsfile Corp
- 4 weeks ago - Zentek Provides Corporate Update - Accesswire
- 4 weeks ago - Zentek Subsidiary Albany Graphite Corp. Achieves Additional 5N Purification Result and Nuclear Graphite EBC Requirements - Accesswire
- 4 weeks ago - Zentek Provides a Preliminary Update on Influenza Countermeasure Candidate Developed Using the Multivalent Aptamer Technology against H1N1 (Seasonal Influenza) - Accesswire